Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SUCRALFATE 1 GM/10 ML SUSP

Sucralfate Oral
$0.1013per ML

Strength

1 g/10mL

Manufacturer

TruPharma LLC

NDC

52817084016

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA213549

On Market Since

4/1/2024

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price History

1W

0.0%

1M

-8.0%

3M

-18.1%

6M

-13.8%

1Y

-27.5%

3Y

N/A

5Y

N/A

All

-50.2%

Generic Alternatives

1 alternative • Same active ingredient

SUCRALFATE 1 GM/10 ML SUSP
Generic
65162006205•Amneal Pharmaceuticals LLC
$0.1206
+19% more

Related Drugs

Same classification

SUCRALFATE 1 GM/10 ML SUSP
Generic
66689030516•VistaPharm, LLC
$0.1087
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
00378920535•Mylan Pharmaceuticals Inc.
$0.1206
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
00713079175•Cosette Pharmaceuticals, Inc.
$0.1206
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
13668075442•Torrent Pharmaceuticals Limited
$0.1206
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
50742038642•Ingenus Pharmaceuticals LLC
$0.1206
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
64380014901•Strides Pharma Inc.
$0.1206
per ML
SUCRALFATE 1 GM/10 ML SUSP
Generic
82182010614•Pacific Pharma, Inc.
$0.1206
per ML
SUCRALFATE 1 GM TABLET
Generic
00093221001•Teva Pharmaceuticals USA Inc.
$0.1889
per EA
SUCRALFATE 1 GM TABLET
Generic
00093221005•Teva Pharmaceuticals USA Inc.
$0.1889
per EA
SUCRALFATE 1 GM TABLET
Generic
00093221098•Teva Pharmaceuticals USA Inc.
$0.1889
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy